According to a recent LinkedIn post from Onego Bio, the company is promoting the final episode of its webinar series, The Power of Trichoderma reesei. The event will feature a live cooking demonstration showcasing Bioalbumen®, a non-animal egg protein produced via precision fermentation, developed in collaboration with partner Sigma.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post indicates that the series has focused on the efficiency of Trichoderma reesei and its role in building a more resilient food system. In this final session, Onego Bio appears to be emphasizing real-world applications, with demonstrations of whipping, aeration, and other core egg functionalities in products such as angel food cake, egg bites, and scrambled eggs.
For investors, the webinar suggests that Onego Bio is moving from technology validation toward demonstrating product performance in consumer-relevant formats. This could signal progress toward commercialization, potentially strengthening the company’s positioning in the alternative protein space and enhancing its appeal to partners and food manufacturers.
The involvement of Sigma, highlighted in the post through a joint cooking demonstration, may indicate an effort to deepen strategic relationships within the food industry. Such collaboration, if it translates into broader adoption or co-development agreements, could support Onego Bio’s path to revenue generation and scale in precision-fermented egg alternatives.